Continuing medical education

Molecular Tumor Board Series 2020: Part I

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genetic/genomic testing, pathology and radiological imaging. Cases discussed include: gallbladder carcinoma, triple negative breast cancer, endometrial cancer and adenocarcinoma of unknown primary.

Upon completion of this activity, participants will be able to:

• Describe the necessary components of an effective molecular tumor board
• Explain how to integrate genomic profiling into oncology treatment plans

Faculty:

• Jason Beland, MD (Cancer Treatment Centers of America)
• Arturo Loaiza-Bonilla, MD, MSEd, FACP (Cancer Treatment Centers of America)
• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Kimberly McGregor, MD (Foundation Medicine)
• Ankur Parikh, DO (Cancer Treatment Centers of America)
• Patricia Rich, MD (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Bradford Tan, MD (Cancer Treatment Centers of America)

Advancements in Cancer Management

This program highlights 5 presentations from a 2019 spring live lecture series. Videos are packaged into short chapters, featuring topics such as: screening high-risk patients, cancer pain management, immunotherapy treatment & adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment and drug-drug interactions.

Upon completion of this activity, participants will be able to:

• Explain the use of multimodal analgesia to manage pain and reduce the use of opioids
• Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of patients with cancer
• Evaluate immuno-oncology approaches in cancer treatment, including patient selection
• Describe the appropriate follow-up protocols for identification of pulmonary nodules
• Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions
• Describe the various treatment options for each of the various pleural effusions

Faculty:

• Kevin Tulipana, DO, FHM (Cancer Treatment Centers of America)
• Stephen Lynch, MD (Cancer Treatment Centers of America)
• Lorenzo Cohen, PhD (The University of Texas MD Anderson Cancer Center)
• Vivek Iyer, MD (Cancer Treatment Centers of America)
• Larry Ladi, MD, FCCP (Cancer Treatment Centers of America)
• Timothy McCay, DO (Cancer Treatment Centers of America)
• Ankur Parikh, DO (Cancer Treatment Centers of America)

Lung Nodules: Evaluation and Diagnostic Approaches

Clinicians require education surrounding lung nodules and need to be updated on new and emerging therapies that will lead to individualized treatment and improved outcomes. As technology improves and new data emerges, recommendations for how and when to follow up with patients with lung nodules continues to evolve. This activity provides a platform to understand the latest guidance.

Upon completion of this activity, participants will be able to:

• Discuss the various diagnostic and staging procedures for lung nodules
• Select the appropriate approach and follow-up for high-risk patients with lung nodules

Faculty:

• Abdul Hamid Alraiyes, MD, FCCP (Cancer Treatment Centers of America)

Dysphagia Palliation in Esophageal Cancer

Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.

Upon completion of this activity, participants will be able to:

• Discuss the various modalities for management of dysphagia
• Select the appropriate modality for management of dysphagia in patients with esophageal cancer
• Explain the goals of palliative treatment in patients with esophageal cancer

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD (Banner MD Anderson)

Molecular Tumor Board Series 1

A multidisciplinary team discusses treatment options for cancer patients in a tumor board format based on data collected from patients, such as, genomic/genetic testing, pathology and radiological imaging. Cases discussed include: squamous cell carcinoma of the scalp, papillary serous ovarian cancer, breast carcinoma and lung adenocarcinoma.

Upon completion of this activity, participants will be able to:

• Utilize skills learned to implement an effective tumor board.
• Describe genomic testing.
• Implement genomic profiling into oncology treatment.

Faculty:

• Pamela Crilley, DO (Cancer Treatment Centers of America)
• Ricardo H. Alvarez, MD, MSc (Cancer Treatment Centers of America)
• Shayma Master Kazmi, MD, RPh (Cancer Treatment Centers of America)
• Arturo Loaiza-Bonilla, MD (Cancer Treatment Centers of America)
• Maurie Markman, MD (Cancer Treatment Centers of America)
• Ankur R. Parikh, DO (Cancer Treatment Centers of America)
• Julian Schink, MD (Cancer Treatment Centers of America)
• Alan Tan, MD (Cancer Treatment Centers of America)

CME Forum 2020: 5th Annual Advancements in Cancer Management

Due to recent recommendations regarding COVID-19 from the CDC and WHO, we are postponing our live CME events scheduled for 2020. We will continue to monitor the situation and reschedule these events once it is safe to do so. Please contact Sarah Lees, National CME Program Manager, with any questions at sarah.lees@ctca-hope.com

CME Forum is a live educational event designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to integrative care for patients with cancer. Panel discussions, case studies and Q & A sessions will take place over dinner to enhance clinician knowledge and competence. Click on the registration links to learn more about topics and faculty for each live event.

Accreditation Statement:

• This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Morehouse School of Medicine and Cancer Treatment Centers of America®. The Morehouse School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
• The Osteopathic Founders Foundation is accredited by the American Osteopathic Association to provide osteopathic continuing medical education.

Credit Designation:

• The Morehouse School of Medicine designates this live activity for a maximum of up to 2.25 AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
• The Osteopathic Founders Foundation (OFF) designates this program for a maximum of 2.25 AOA Category 1-A Credits. OFF will report CME and specialty credits commensurate with the extent of the osteopathic physician’s participation in this activity.

Multidisciplinary Management of Rectal Cancer in Young Adults: Facts and Controversies

Due to recent recommendations regarding COVID-19 from the CDC and WHO, we are postponing our live CME events scheduled for March 2020. We will continue to monitor the situation and reschedule these events once it is safe to do so. At this time, events for April and May will proceed as scheduled but we will keep any registrants posted if those programs need to be changes as well. Please contact Sarah Lees, National CME Program Manager, with any questions at sarah.lees@ctca-hope.com

This educational activity is designed to educate clinicians such as oncologists and gastroenterologists as well as physician-trainees, pharmacists, nurses and allied health professionals involved in the care and management of patients suffering from rectal cancer. In recent years, the average age of patients with rectal cancer has decreased. These younger patients require different treatment approaches. This activity is focused on sharing the various protocols for managing rectal cancer in young adults, focusing on how recommendations differ in a younger population, and emerging evidence of the effectiveness of various approaches in patients under 50.

Upon completion of this activity, participants will be able to:

• Explain the different approaches for managing rectal cancer in young adults
• Identify the appropriate approach for the treatment of rectal cancer in young adults

Faculty:

• Toufic Kachaamy, MD, FASGE (Cancer Treatment Centers of America)
• Madappa Kundranda, MD, PhD, FACP (Banner MD Anderson)
• Nitin Mishra, MBBS, MPH (Mayo Clinic – Phoenix)